JP2009535418A5 - - Google Patents

Download PDF

Info

Publication number
JP2009535418A5
JP2009535418A5 JP2009509987A JP2009509987A JP2009535418A5 JP 2009535418 A5 JP2009535418 A5 JP 2009535418A5 JP 2009509987 A JP2009509987 A JP 2009509987A JP 2009509987 A JP2009509987 A JP 2009509987A JP 2009535418 A5 JP2009535418 A5 JP 2009535418A5
Authority
JP
Japan
Prior art keywords
compound according
composition
compound
phenyl
hexanoyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009509987A
Other languages
English (en)
Japanese (ja)
Other versions
JP5570211B2 (ja
JP2009535418A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/067736 external-priority patent/WO2007130890A2/en
Publication of JP2009535418A publication Critical patent/JP2009535418A/ja
Publication of JP2009535418A5 publication Critical patent/JP2009535418A5/ja
Application granted granted Critical
Publication of JP5570211B2 publication Critical patent/JP5570211B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009509987A 2006-05-04 2007-04-30 治療化合物 Expired - Fee Related JP5570211B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US74639306P 2006-05-04 2006-05-04
US60/746,393 2006-05-04
PCT/US2007/067736 WO2007130890A2 (en) 2006-05-04 2007-04-30 Cyclopentane-derivatives and their use as ocular hypotensive agents

Publications (3)

Publication Number Publication Date
JP2009535418A JP2009535418A (ja) 2009-10-01
JP2009535418A5 true JP2009535418A5 (enExample) 2010-07-01
JP5570211B2 JP5570211B2 (ja) 2014-08-13

Family

ID=38668464

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009509987A Expired - Fee Related JP5570211B2 (ja) 2006-05-04 2007-04-30 治療化合物

Country Status (7)

Country Link
US (1) US7476755B2 (enExample)
EP (1) EP2029518A2 (enExample)
JP (1) JP5570211B2 (enExample)
AU (1) AU2007248180B2 (enExample)
BR (1) BRPI0711187A2 (enExample)
CA (1) CA2650952A1 (enExample)
WO (1) WO2007130890A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090016981A1 (en) * 2006-05-03 2009-01-15 Allergan, Inc. Therapeutic compounds
JP5566902B2 (ja) * 2007-11-29 2014-08-06 アラーガン インコーポレイテッド プロスタグランジン活性を有する置換シクロペンタン類
US8455547B2 (en) * 2008-02-05 2013-06-04 Allergan, Inc. Substituted cyclopentanes having prostaglandin activity
RU2500674C2 (ru) * 2008-05-09 2013-12-10 Аллерган, Инк. Терапевтические соединения
AU2015269064B2 (en) * 2014-06-06 2020-02-13 Allergan, Inc. Novel EP4 agonists as therapeutic compounds

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4166452A (en) 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
US4256108A (en) 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
DE3100578A1 (de) 1980-01-25 1982-02-11 Farmitalia Carlo Erba S.p.A., 20159 Milano Isoxazolyl- und isoxazolinyl-prostaglandine, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische und veterinaermedizinische mittel
GB2067994B (en) * 1980-01-25 1984-02-08 Erba Farmitalia Isoxazolyl and isoxazolinyl prostaglandins
US4265874A (en) 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US5462968A (en) * 1994-01-19 1995-10-31 Allergan, Inc. EP2 -receptor agonists as agents for lowering intraocular pressure
US5902726A (en) 1994-12-23 1999-05-11 Glaxo Wellcome Inc. Activators of the nuclear orphan receptor peroxisome proliferator-activated receptor gamma
JP2001527063A (ja) * 1998-12-24 2001-12-25 小野薬品工業株式会社 ω−シクロアルキル−プロスタグランジンE2誘導体
BR0211364A (pt) * 2001-07-23 2004-07-13 Ono Pharmaceutical Co Composição farmacêutica para tratamento de doenças associadas com redução na massa óssea compreendendo o agonista ep4 como componente ativo
US7091231B2 (en) * 2004-12-10 2006-08-15 Allergan, Inc. 12-Aryl prostaglandin analogs

Similar Documents

Publication Publication Date Title
JP2009535426A5 (enExample)
ES2394838T3 (es) Análogos 12-ARIL de prostaglandinas
JP2011500818A5 (enExample)
IL264541A (en) History of sulfamolepyrolamide and their use as drugs for the treatment of jaundice b
JP2014514322A5 (enExample)
JP2009535418A5 (enExample)
RU2007133581A (ru) Замещенные гамма-лактамы в качестве терапевтических агентов
JP2010530897A5 (enExample)
JP2010510232A5 (enExample)
CA2614529A1 (en) Pyridazinone derivatives as thyroid hormone receptor agonists
JP2005526011A5 (enExample)
JP2010536761A5 (enExample)
JP2009543794A5 (enExample)
JP2009541224A5 (enExample)
JP2009536967A5 (enExample)
CN113226296A (zh) Ssao抑制剂及其用途
JP2009538328A5 (enExample)
KR20100086485A (ko) 치료적 치환된 락탐
LU86747A1 (fr) Nouveaux derives de dihydrobenzofuranne-et de chromane-carboxamides,leurs procedes de preparation et leur utilisation comme neuroleptiques
JP2013513607A5 (enExample)
AR052876A1 (es) Uso de compuestos de ciclopentano y ciclopentanona substituidos para la fabricacion de un medicamento para tratamiento del glaucoma o de la hipertension ocular, composicion y compuestos correspondientes
JP2011503089A5 (enExample)
JP2009538340A5 (enExample)
RU2015156196A (ru) Антифиброгенные соединения, способы и их применение
JP2010516779A5 (enExample)